A GPR40 agonist GW9508 suppresses CCL5, CCL17, and CXCL10 induction in keratinocytes and attenuates cutaneous immune inflammation

Journal of Investigative Dermatology

Volumn 131, Issue 8, 2011, Pages 1660-1667

  Fujita, Tomoko ^a   Matsuoka, Toshiyuki ^a   Honda, Tetsuya ^a   Kabashima, Kenji ^a   Hirata, Takako ^a   Narumiya, Shuh ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR AGONIST; G PROTEIN COUPLED RECEPTOR 40; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GW 9508; HAPTEN; INTERLEUKIN 11; INTERLEUKIN 24; INTERLEUKIN 33; PERTUSSIS TOXIN; RANTES; SMALL INTERFERING RNA; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; ATTENUATION; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO CULTURE; KERATINOCYTE; MOUSE; NONHUMAN; OTITIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SKIN INFLAMMATION; TREATMENT OUTCOME;

EID: 79960339155     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.123     Document Type: Article

References (36)

1. Boukamp P, Petrussevska RT, Breitkreutz D et al. (1988) Normal keratiniza-tion in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol106:761-71 (Pubitemid 18089976)
2. Briscoe CP, Peat AJ, Mc Keown SC et al. (2006) Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules. Br J Pharmacol 148:619-28 (Pubitemid 43993052)
3. Castellani ML, Bhattacharya K, Tagen M et al. (2007) Anti-chemokine therapy for inflammatory diseases. Int J Immunopathol Pharmacol 20:447-53 (Pubitemid 47534148)
4. Feingold KR (2007) Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J Lipid Res 48:2531-46 (Pubitemid 350272838)
5. Girolomoni G, Pastore S, Cavani A et al. (2004) The role of chemokines in inflammatory skin diseases. Ernst Schering Res Found Workshop 44:191-225
6. Hirasawa A, Tsumaya K, Awaji T et al. (2005) Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 11:90-4 (Pubitemid 40215843)
7. 3 signaling suppresses skin inflammation in murine contact hypersensitivity. J Allergy Clin Immunol124:809-18 e802
8. Inagaki N, Shiraishi N, Igeta K et al. (2006) Inhibition ofscratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone. Eur J Pharmacol 546:189-96 (Pubitemid 44331846)
9. Itoh Y, Kawamata Y, Harada M et al. (2003) Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422:173-6 (Pubitemid 36362750)
10. 2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat Immunol 4:694-701 (Pubitemid 36874447)
11. Kakinuma T, Nakamura K, Wakugawa M et al. (2001) Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. JAllergy Clin Immunol 107:535-41 (Pubitemid 32210037)
12. Kakkar R, Lee RT (2008) The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 7:827-40
13. Karsak M, Gaffal E, Date R et al. (2007) Attenuation of allergic contact dermatitis through the endocannabinoid system. Science 316:1494-7 (Pubitemid 46906619)
14. Klar J, Schweiger M, Zimmerman R et al. (2009) Mutations in the fatty acid transport protein 4 gene cause the ichthyosis prematurity syndrome. Am J Hum Genet 85:248-53
15. Kunikata T, Yamane H, Segi E et al. (2005) Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3. Nat Immunol 6:524-31 (Pubitemid 41716766)
16. Lee HM, Yuk JM, Shin DM et al. (2009) Apurinic/apyrimidinic endonuclease 1 is a key modulator of keratinocyte inflammatory responses. J Immunol 183:6839-48
17. Levy JA (2009) The unexpected pleiotropic activities of RANTES. J Immunol 182:3945-6
18. Lo BK, Yu M, Zloty D et al. (2010) CXCR3/ligands aresignificantly involved in the tumorigenesis of basal cell carcinomas. Am J Pathol 176:2435-46
19. Mori T, Kabashima K, Yoshiki R et al. (2008) Cutaneous hypersensitivities to hapten are controlled by IFN-γ-upregulated keratinocyte Th1 chemo-kinesand IFN-γ-downregulated langerhanscell Th2 chemokines.JInvest Dermatol 128:1719-27 (Pubitemid 351847394)
20. Nakae S, Komiyama Y, Narumi S et al. (2003) IL-1-induced tumor necrosis factor-α elicits inflammatory cell infiltration in the skin by inducing IFN-γ-inducible protein 10 in the elicitation phase of the contact hypersensitivity response. Int Immunol 15:251-60 (Pubitemid 36267117)
21. Nance DM, Sanders VM (2007) Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun 21:736-45 (Pubitemid 47002215)
22. Neves SR, Ram PT, Iyengar R (2002) G protein pathways. Science 296:1636-9 (Pubitemid 34579147)
23. Nickel RG, Casolaro V, Wahn U et al. (2000) Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol164:1612-6 (Pubitemid 30067281)
24. Oh DY, Talukdar S, Bae EJ et al. (2010) GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142:687-98
25. Park CW, Lee BH, Han HJ et al. (2005) Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis. Br J Dermatol 152:1173-81 (Pubitemid 40933414)
26. Pastore S, Mascia F, Girolomoni G (2006) The contribution of keratinocytes to the pathogenesis of atopic dermatitis. Eur J Dermatol16:125-31
27. Proksch E, Brandner JM, Jensen JM (2008) The skin: an indispensable barrier. Exp Dermatol 17:1063-72
28. Pushparaj PN, Tay HK, H'Ng SC et al. (2009) The cytokine interleukin-33 mediates anaphylactic shock. Proc Natl Acad Sci USA 106:9773-8
29. Rosen H, Sanna MG, Cahalan SM et al. (2007) Tipping the gatekeeper: S1P regulation of endothelial barrier function. Trends Immunol28:102-7 (Pubitemid 46283694)
30. Saeki H, Tamaki K (2006) Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. J Dermatol Sci 43:75-84 (Pubitemid 44094007)
31. Tanaka K, Roberts MH, Yamamoto N et al. (2006) Upregulating promoter polymorphisms of RANTES relate to atopic dermatitis. Int J Immunogenet 33:423-8 (Pubitemid 44760237)
32. Tsuda T, Tohyama M, Yamasaki K et al. (2003) Lack of evidence for TARC/ CCL17 production by normal human keratinocytes in vitro. J Dermatol Sci 31:37-42 (Pubitemid 36286957)
33. Ueta M, Matsuoka T, Narumiya S et al. (2009) Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis. JAllergy Clin Immunol123:466-71
34. Xiao T, Kagami S, Saeki H et al. (2003) Both IL-4and IL-13 inhibit the TNF-α and IFN-γ enhanced MDC production in a human keratinocyte cell line, Ha Ca T cells. J Dermatol Sci 31:111-7 (Pubitemid 36379061)
35. Yamada H, Matsukura M, Yudate T et al. (1997) Enhanced production of RANTES, an eosinophil chemoattractant factor, by cytokine-stimulated epidermal keratinocytes. Int Arch Allergy Immunol 114 (Suppl 1):28-32 (Pubitemid 27455062)
36. H17 cell expansion. Nat Med 15:633-40